Trade FBLG stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
FibroBiologics, Inc. (FBLG) is trading at US$1.43, down 3.70% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$9.59M. Over the past 52 weeks, FBLG has traded between US$0.62 and US$12.40. On Syfe you can trade FBLG with $0 commission and add it to your watchlist.
| Previous close | US$1.49 |
|---|---|
| Market cap | US$9.59M |
| 52-week range | US$0.62 – US$12.40 |
| Volume | 130.7K |
| Exchange | US |
Add to Watchlist
Set Price Alert
FibroBiologics, Inc.
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.
Year: 2024
FibroBiologics Closes Private Placement
Jun 29, 9:40 PM · MT Newswires
FibroBiologics Says US Patent for Therapeutic Use of Fibroblasts in Wound Healing Receives Notice of Allowance
Jun 22, 12:58 PM · MT Newswires
FibroBiologics Doses First Patients in Phase 1/2 Trial of CYWC628 for Diabetic Foot Ulcers
Jun 16, 1:01 PM · MT Newswires
FibroBiologics Closes $3 Million Public Offering
Apr 2, 8:58 PM · MT Newswires
FibroBiologics Reports 1-for-20 Reverse Stock Split
Mar 25, 8:59 PM · MT Newswires
FibroBiologics, Inc. (FBLG) stock is trading at US$1.43, -3.70% from the previous close of US$1.49.
The market cap for FibroBiologics, Inc. (FBLG) stock is approximately US$9.59M.
The 52-week high for FibroBiologics, Inc. (FBLG) stock is US$12.40.
The 52-week low for FibroBiologics, Inc. (FBLG) stock is US$0.62.
FibroBiologics, Inc. (FBLG) does not currently pay a dividend.
Stay on top of FBLG
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
